XOMA Royalty Corp 8.625% Series A Preferred Stock

XOMAP

Market cap $23.1M

26.30 USD

+0.22

0.84%

At close Updated Nov 3, 11:03 AM EST

1 day

0.84%

5 days

-0.75%

1 month

-0.23%

3 months

1.74%

6 months

0.08%

Year to date

1.62%

1 year

2.14%

5 years

7.74%

10 years

7.74%

About: XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Employees: 13

Healthcare Biotechnology

–

Funds holding %

of 7,505 funds

Explore Fund Trends

–

Analysts bullish %

See Analyst Outlook

–

Positive news %

Check Journalist POV